Question

I am a breastfeeding mother and i want to know if it is safe to use EINECS 213-907-3? Is EINECS 213-907-3 safe for nursing mother and child? Does EINECS 213-907-3 extracts into breast milk? Does EINECS 213-907-3 has any long term or short term side effects on infants? Can EINECS 213-907-3 influence milk supply or can EINECS 213-907-3 decrease milk supply in lactating mothers?

EINECS 213-907-3 lactation summary

EINECS 213-907-3 is safe in breastfeeding
  • DrLact safety Score for EINECS 213-907-3 is 1 out of 8 which is considered Safe as per our analyses.
  • A safety Score of 1 indicates that usage of EINECS 213-907-3 is mostly safe during lactation for breastfed baby.
  • Our study of different scientific research also indicates that EINECS 213-907-3 does not cause any serious side effects in breastfeeding mothers.
  • Most of scientific studies and research papers declaring usage of EINECS 213-907-3 safe in breastfeeding are based on normal dosage and may not hold true for higher dosage.
  • Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Answer by Dr. Ru: About EINECS 213-907-3 usage in lactation

Pharmacokinetic data (high volume of distribution and molecular weight) would explain the minimal excretion into breast milk mentioned in two older reports. Due to a poor oral bioavailability, appearance in the infant's plasma from ingested milk is regarded as nil or scanty, except in premature infants or during the immediate neonatal period who may show an increased intestinal absorption.

Answer by DrLact: About EINECS 213-907-3 usage in lactation

Limited data indicate that EINECS 213-907-3 is minimally excreted into breastmilk following intramuscular administration of colistimethate. Because EINECS 213-907-3 is poorly absorbed orally, it is unlikely to be absorbed in appreciable amounts by the infant or adversely affect the breastfed infant. However, no studies have evaluated serum levels or adverse effects in breastfed infants whose mothers were receiving colistimethate. Breastfeeding is acceptable with the use of inhaled EINECS 213-907-3 or colistimethate.

Alternate Drugs for Antidiarrheals: Intestinal anti-infectives, adsorbents, electrolytes, anti-propulsive, anti-inflammatory and microorganisms agents. ATC A07

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.